Lui Alfred Fu Kong - 03 Jan 2022 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role: Director
Signature: Alfred Lui, M.D.
Issuer symbol: EMMA
Transactions as of: 03 Jan 2022
Net transactions value: +$15,800
Form type: 4
Filing time: 05 Jan 2022, 15:33:27 UTC
Previous filing: 30 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EMMA	Common stock, $0.001 par value	Purchase	$15,800	+10,000		$1.58^*	10,000	03 Jan 2022	Direct	F1
holding	EMMA	Common stock, $0.001 par value						32,358	03 Jan 2022	Alfred and Janet Lui Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.65, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.65, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).